96932 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Insulin-like growth factor binding protein
PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#2LOT RELEASE ASSAYS FOR IGF-1/IGFBP COMPLEXES
#3NON-RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN CONCENTRATE
#4MODULATION OF MAMMALIAN CELL LINEAGE BY SYNTHETIC IMMODULINS
#5REGENERATION OF MAMMALIAN TISSUES USING SYNTHETIC IMMODULINS
#6CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#7PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#8Immodulator peptides covalently modified with small molecules
#9PRODUCTION METHOD FOR ORGANOID
#10METHODS AND COMPOSITIONS FOR TREATING A DISEASE OR DISORDER
#11Non-recombinant human insulin-like growth factor binding protein concentrate
#12Igniting network nodes in a multi-hop wireless network
#13PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
#14CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#15Heparin-binding domain of IGFBP-2 in the treatment of metabolic disorders
#16Recombinant proteins and uses thereof
#17COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR IMPROVEMENT OF BONE DISORDERS
#18Peptides and combination of peptides for use in immunotherapy against cancers
#19Compounds, compositions and uses thereof for improvement of bone disorders
#20HLA-DR binding peptides and their uses
#21Peptides and combination of peptides for use in immunotherapy against cancers
#22COMPOUNDS AND METHODS FOR TREATING OBESITY AND CONTROLLING WEIGHT
#23CCN3 and CCN3 peptides and analogs thereof for therapeutic use
#24IGFBP-3 derivatives and uses thereof
#25Wnt signaling inhibitor comprising insulin-like growth factor-binding protein
#26RADIATION EXPOSURE DIAGNOSTIC MARKER IGFBP-5, COMPOSITION FOR RADIATION EXPOSURE DIAGNOSIS BY MEASURING THE EXPRESSION LEVEL OF THE MARKER, RADIATION EXPOSURE DIAGNOSTIC KIT COMPRISING THE COMPOSITION, AND METHOD FOR DIAGNOSING RADIATION EXPOSURE USING THE MARKER
#27CCN3 and CCN3 peptides and analogs thereof for therapeutic uses
#28Method for producing proteins in that lack detectable cross binding activity to antibodies against host cell antigens
#29CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY
#30Cell-permeable peptide inhibitors of the JNK signal transduction pathway
#31Soluble non-depot insulin conjugates and uses thereof
#32CCN3 peptides and analogs thereof for therapeutic use
#33Wnt Signaling Inhibitor Comprising Insulin-Like Growth Factor-Binding Protein
#34FOLLISTATIN DOMAIN CONTAINING PROTEINS
#35HLA-DR BINDING PEPTIDES AND THEIR USES
#36Method of Inhibiting Angiogenesis, Tumorigenesis and Cathepsin Activity
#37Method for treating cartilage disorders
#38MEDICAL USES AND THERAPIES BASED UPON THE ACTION OF AZUROCIDIN ON IGFBP-1
#39FOLLISTATIN DOMAIN CONTAINING PROTEINS
#40Use of IGFBP-2 in Senescence Diseases and for the Maintenance of Organ Functions
#41CCN3 peptide
#42Mutant IGFBP-3 molecules that do not bind to IGFs, but retain their ability to functionally bind IGFBP-3 receptor
#43Mutants of IGF Binding Proteins and Methods of Production of Antagonists Thereof
#44Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
#45Altered insulin-like growth factor binding proteins
#46Insulin-Like Growth Factor Binding Protein-4 Compounds and Methods for Inhibiting Angiogenesis and Tumor Growth in Mammalian Cells
#47Article of manufacture
#48Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
#49Antibodies to insulin-like growth factor binding protein and uses thereof
#50Blockade of Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma by Insulin-Like Growth Factor Binding Protein-3 (Igfbp-3)
#51Metal-binding therapeutic peptides
#52Metal-binding therapeutic peptides
#53Mutant IGFBP-3 molecules that do not bind to IGFS, but retain their ability to functionally bind IGFBP-3 receptor
#54Metal-binding therapeutic peptides
#55Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress
#56Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
#57Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides
#58Insulin-like growth factor binding protein
#59Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
#60IGF-I responsive gene and use thereof
#61Purified rhIGF-I/rhIGFBP-3 complexes and their method of manufacture
#62Altered insulin-like growth factor binding proteins
#63IGF antagonist peptides
#64Prostacyclin-stimulating Factor-2
#65Methods for delivering MBD peptide-linked agent into cells under conditions of cellular stress
#66IGF-binding protein-derived peptide or small molecule
#67Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
#68CCN1 transgenic animals
#69Binding proteins as chemotherapy
#70Insulin-like growth factor binding protein (IGFBP-5)
#71Mutant IGFBP-3 molecules that do not bind to IGFS, but retain their ability to functionally bind IGFBP-3 receptor
#72Mutants of igf binding proteins and methods of production of antagonists thereof